Biotherapeutics Virus Removal Filters Market Trends [2031]

Report Description

Biotherapeutics Virus Removal Filters Market Outlook 2031

The global biotherapeutics virus removal filters market size was USD 425 Million in 2022 and is likely to reach USD 919 Million by 2031, expanding at a CAGR of 8.1% during 2023–2031. The market growth is attributed to the increasing awareness of the healthcare benefits of biomedicine.

Increasing complexity of viral diseases is projected to impel the market during the assessment period. A singular drug type cannot be used to treat different types of viral diseases. As a result, there is a growing demand for personalized medicine and biotherapeutics, propelling market growth.  It has been observed that combination drug therapy and biotherapeutics are very effective in the treatment of high-risk illnesses such as HIV, further facilitating demand.

Get Free Sample Report

Additionally, the rampant proliferation of viral infections in recent years is expected to boost market growth. As a result of unprecedented population growth, the spread of viral infections has increased considerably in the last few decades.  For instance,

• According to an October 2022 report published by the National Institutes of Health, a massive 60% of infectious diseases, and 75% of emerging infections are transmitted through animals. Approximately 2/3^rd of these are transmitted through wildlife.

The COVID-19 pandemic boosted the market considerably owing to the considerable R&D activities dedicated to containing the virus. The rampant spread of the virus put significant pressure on governments all over the world to produce a treatment measure. This spread was especially apparent in densely populated regions of the world, thus there was an urgent need for a cure. As a result, considerable research and development went into the production of an antibody, thus propelling market growth. For instance,

• According to an April 2022 report published by the National Institutes of Health, the effective development of the COVID-19 vaccine reduced the fatality rates by a massive 50% in the high-income regions of the world. It also an 89% reduction rates in COVID-related hospitalizations.

Impact of Artificial Intelligence (AI) in Biotherapeutics Virus Removal Filters Market

The introduction of Artificial Intelligence (AI) to the biopharmaceutical sector is projected to accelerate market growth considerably.  AI is expected to revolutionize all sectors of the biopharmaceutical industry such as drug discovery, development, and repurposing. AI is used to process and automate large amounts of data and provide necessary insights into biopharmaceutical development. Machine and deep learning techniques mimic human neurons and can be used to study the effects of different types of pharmaceuticals.

• According to an October 2020 report published by the National Institutes of Health, the International Business Machine Watson Supercomputer was developed using AI technology to suggest effective treatment measures for cancer.

Biotherapeutics Virus Removal Filters Market Dynamics

Get Free Sample Report

Drivers

Rapidly increasing population is projected to boost market growth over the forecast period. The surge in population, coupled with increasing population density, creates high probability of rapid spread of viral pandemics. As a result, there is an increasing demand for solutions. Biotherapeutics are proven to be highly effective in containing the spread of highly serious viral illnesses and have grown to be one of the most used drugs in the last few decades.

Restraints

High costs associated with the research and development of biotherapeutics have the potential to hinder market growth. The process of development of effective biotherapeutic treatments is lengthy, complex, and requires considerable capital. Every drug has to go through several trials before being approved by the FDA, which makes the process of production and distribution fairly time-consuming thereby, hampering output.

• According to a March 2020 report published by the National Institutes of Health, the recent cost required to develop a new drug which includes failed FDA trials, is approximately USD 985 million. Recent estimates are projected to go as high as USD 2.8 billion.

Emerging Opportunities

Growing research dedicated toward DNA and RNA technology is projected to streamline the market over the forecast period. Owing to the advancements in medical science and technology, nano-based drugs and regenerative therapies are being developed for the efficient treatment of viral diseases. Additionally, the development of artificially manufactured monoclonal antibodies is projected to boost the efficacy of most biotherapeutic medicines.

• For instance, according to a January 2021 report published by the National Institutes of Health, the creation of biotherapeutics for the treatment of serious illnesses such as COVID-19 and the Ebola virus has grown significantly in the last few years.

 Scope of the Biotherapeutics Virus Removal Filters Market Report

The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Market Segment Insights

Technology Segment Analysis

Based on technology, the biotherapeutics virus removal filters market is divided into size exclusion technology and depth filtration technology. The depth filtration technology segment is expected to display significant growth during the projection period owing to the success of this method. This method displayed considerable precision over the size exclusion technology, enabling segment growth. Additionally, the recent development of asymmetric depth filtration, a variant of this technology, showed considerable promise in the efficient filtration of pathogens from DNA.

• According to an August 2022 report published by the National Institute of Health, the asymmetric depth filtration technology effectively captures nanoparticles and pathogens much smaller in size as compared to those captured by size filtration technologies.

Get Free Sample Report

Application Segment Analysis

On the basis of application, the global market is segregated into enzymes, blood & plasma, monoclonal antibodies, and proteins. The monoclonal antibodies segment is projected to register a rapid growth rate during the forecast period owing to advancements in the production of lab-grown antibodies. These antibodies have proven to be highly effective in the treatment of serious viral illnesses. They boost the immune system, thereby resulting in quicker recovery.

• According to a January 2020 report published by the Journal of Biomedical Sciences, since the creation of the first lab-generated monoclonal antibody over 25 years ago, significant progress has been made in the creation of quicker and more effective technologies.

The blood & plasma segment is also projected to show considerable growth as they serve as a temporary fix in the absence of specific treatments. The white blood cells and platelets present in blood and plasma protect the body against pathogens. Thus, the transfusion of these fluids rapidly boosts the immune system in case of emergencies. Blood and plasma are also much more readily available than other bodily secretions. For instance,

• According to a June 2023 report published by the World Health Organization, a massive 118.5 million blood donations were conducted globally. Additionally, 79% of high-income nations and 63% of middle-income nations have effective blood policies in place.

Get Free Sample Report

End-user Segment Analysis

Based on end-user, the market is segmented into academic institutions, biopharmaceutical companies, clinical research organizations, and others. The biopharmaceutical companies segment is expected to dominate the market during the forecast period owing to the growing demand for biotherapeutic drugs.

Biotherapeutic drugs have proven to be considerably quick and effective in the treatment of serious illnesses. Thus, the demand for these drugs has increased considerably over the last few decades. Therefore, a growing number of Biopharma companies are turning to the development of biotherapeutics.

Regional Outlook

In terms of region, the global biotherapeutics virus removal filters market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period owing to the presence of advanced medical infrastructure. In high-income regions such as North America, considerable government funds are dedicated towards medical advances and R&D activities. These factors are projected to impel the market during the assessment period. For instance,

• According to a June 2023 report published by the World Health Organization, a massive 81% growth rate was observed in voluntary blood and plasma donations in the regions of America.

The Asia Pacific region is projected to register a considerable CAGR over the projection owing to the rapid development of R&D activities in this region. This growth is especially observable in the middle-income countries located in the South East as well as South Asia. For instance,

• According to a June 2023 report published by the World Health Organization, the highest growth rate of blood and plasma donations (127%) was observed in the Southeast part of this region.

  Get Free Sample Report